Top Healthcare Stocks To Watch Now - November 15th

Key Points

• Eli Lilly, Moderna, and Johnson & Johnson were identified as healthcare stocks to watch based on their high recent dollar trading volume.
• Eli Lilly shares rose $16.77 to $1,444.05 on Friday, near their 52-week high of $1,460; the company has a market capitalization of $1.36 trillion.
• Moderna fell $7.98 to $223.37, while Johnson & Johnson gained $2.26 to $285.78; both companies’ shares traded below their average recent volumes.

Eli Lilly and Company, Moderna, and Johnson & Johnson are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies whose businesses are related to healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, hospitals, and health insurers. For investors, they offer exposure to healthcare demand and innovation, but their performance can be affected by factors such as regulation, clinical-trial results, patent expirations, and insurance or reimbursement policies. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY stock traded up $16.77 during trading on Friday, reaching $1,444.05. 2,080,606 shares of the company were exchanged, compared to its average volume of 3,003,279. The company has a market cap of $1.36 trillion, a P/E ratio of 46.87, a PEG ratio of 1.71 and a beta of 0.40. Eli Lilly and Company has a 52-week low of $850.51 and a 52-week high of $1,460.00. The stock's 50 day moving average price is $1,242.25 and its 200 day moving average price is $1,110.30. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.00 and a current ratio of 1.39.

Read Our Latest Research Report on LLY

Moderna (MRNA)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.

MRNA traded down $7.98 on Friday, hitting $223.37. 8,041,048 shares of the company were exchanged, compared to its average volume of 15,522,397. Moderna has a fifty-two week low of $22.28 and a fifty-two week high of $280.80. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.47 and a current ratio of 3.62. The firm has a market capitalization of $90.38 billion, a P/E ratio of -31.46 and a beta of 1.16. The business's fifty day moving average is $201.67 and its 200 day moving average is $96.41.

Read Our Latest Research Report on MRNA

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of JNJ stock traded up $2.26 during midday trading on Friday, reaching $285.78. 6,279,519 shares of the company traded hands, compared to its average volume of 7,472,752. The firm's 50 day simple moving average is $266.97 and its two-hundred day simple moving average is $249.85. Johnson & Johnson has a 1-year low of $193.55 and a 1-year high of $288.11. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.02 and a quick ratio of 0.74. The firm has a market cap of $687.95 billion, a PE ratio of 43.30, a price-to-earnings-growth ratio of 2.80 and a beta of 0.22.

Read Our Latest Research Report on JNJ

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.